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ABSTRACT
Background." Eczema herpeticum is an uncommon manifestation of an infection with herpes simplex
virus (HSV). The disease is primarily seen in patients with histories of atopie eczema. Eczema
herpetieum may be a life-threatening illness, but the mortality is felt to be <10% with modern
antiviral and antibacterial agents. The use of aeyelovir for other viral infections secondary to
herpesvirus in pregnancy has been well documented. The authors now present a ease report of
eczema herpetieum treated with aeyelovir during pregnancy.
Case: A patient with a history of eczema herpetieum presented in pregnancy with a recurrence.
She was successfully treated with intravenous (IV) aeyelovir with good maternal and fetal outcome.
Conclusion: Aeyelovir may be utilized in pregnancy for several manifestations ofHSV including
eczema herpetieum. (C) 1997 Wiley-Liss, Inc.
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czema herpeticum, also known as Kaposi’s vari-
celliform eruption, is a viral vesiculopustular ex-
anthem secondary to an infection with herpes sim-
plex virus (HSV). HSV type is primarily the
responsible agent, although type II has also been
described. The disproportionate number of HSV
infections ascribed to type may be secondary to
an underestimation because typing of the virus is
usually not performed, Patients with atopic eczema
appear to be particularly susceptible. Patients with
other dermatologic conditions including autosomal
dominant ichthyosis vulgaris, Darier’s disease, fa-
milial benign pemphigus, pemphigus foliaceous,
and congenital ichthyosiform erythroderma are pre-
disposed to the disorder.
The manifestations of eczema herpeticum may
range from a mild transient rash to a fatal illness.
The cause of fatalities seems to be an extensive
viremia with involvement of the internal organs by
a secondary bacterial infection, usually [3-hemolytic
streptococcus or Staphylococcus aureus.
Case Report
B. A., a 20-year-old white female, presented to the
emergency room with a recurrent facial rash. Her
medical history was significant for asthma requiring
several hospital admissions per year. She had had
eczema herpeticum diagnosed year earlier. Her
prior episode began when she noted painful, raised
flesh-colored blisters on her lips. The legions spread
across her cheeks, nose, and forehead. A skin cul-
ture was positive for HSV. An eye exudate culture
revealed S. aureus. She was treated with intravenous
(IV) nafcillin and acyclovir and discharged home
with the rash almost completely resolved. An oph-
thalmologic examination in the hospital revealed
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ocular HSV involvement. The ocular involvement
resolved without residual impairment. She was dis-
charged home on oral dicloxacillin and acyclovir.
She presented to the emergency room year later
with a recurrent facial rash. She had had a positive
pregnancy test approximately 6 weeks prior to her
presentation, although she was uncertain of her last
menstrual period.
Her facial rash began approximately 36 h prior
to her presentation. She had diffuse, mildly tender,
bilateral anterior cervical lymphadenopathy. Her
skin demonstrated a raised erythematous rash coa-
lescing over the face with angioedema. There was
no eye involvement or extension beyond the face
on admission. The lesions were red and raised with
crusting (Fig. 1). They were of the same initial
distribution and character as her previous rash from
eczema herpeticum. She was afebrile. A diffuse
maculopapular rash with tender crusting lesions was
noted. Aerobic, anaerobic, and HSV cultures were
obtained. A sonogram revealed a 12-week single
viable intrauterine pregnancy. The patient was
started on IV acyclovir with rapid resolution of the
lesions. The HSV culture returned positive. She
was discharged home on oral acyclovir (200 mg 5
times a day for 7 days) after 5 days of hospitalization
and marked improvement in the rash.
The remainder of her pregnancy was compli-
cated by an admission for bronchitis and asthma at
37 weeks gestation. Her fundal height grew appro-
priately throughout her pregnancy. She had normal
sonograms at 28 and 37 weeks gestation. She pre-
sented to labor and delivery at 38-2/7 weeks gesta-
tion with rupture of the membranes. She spontane-
ously began to labor. After pitocin augmentation,
she delivered a viable female infant with a birth
weight of 3,380 g and Apgars of 9/9. She and her
infant had uncomplicated postpartum courses.
They are currently doing well.
DISCUSSION
We describe a case of eczema herpeticum during
pregnancy. Eczema herpeticum is a disease most
frequently caused by HSV type but sometimes
HSV type II. Swart and colleagues previously de-
scribed the treatment of 3 cases of eczema herpeti-
cum with acyclovir. There are only 2 other reports
of acyclovir treatment ofeczema herpeticum during
pregnancy.
5,6 Eczema herpeticum is a disease with
widely ranging degrees of severity, from very mild
symptoms to a rapidly fatal illness. Since the utiliza-
tion of acyclovir for other herpes-related illnesses
in pregnancy has been successful and the pharmaco-
kinetics have been previously delineated, we used
IV acyclovir with good therapeutic response in a
patient with eczema herpeticum. This pregnant pa-
tient subsequently delivered at term with an un-
complicated postpartum course for mother and
child.
Acyclovir is now well established in the arma-
mentarium used against HSV infections. It has been
shown to be effective in treating primary, recrudes-
cent, and life-threatening HSV infections in normal
and immunocompromised adults, as well as new-
born infants. There are numerous case reports of
the use of acyclovir in pregnancy. The pharmacoki-
netics of acyclovir in pregnancy have also been ex-
amined. Brown and associates presented informa-
tion on the oral administration of acyclovir to
women with histories of recurrent genital herpes
at the Interscience Conference on Antimicrobial
Agents and Chemotherapy in New York in 1987.
The peak levels observed in term pregnant patients
were somewhat lower than those observed in non-
pregnant patients after oral dosing with 200 mg
of acyclovir. The ratio of plasma concentration of
acyclovir in mothers-to-newborns was 1.12. Lau and
colleagues studied the plasma concentrations of
acyclovir in breast-feeding women. They calculated
a plasma-to-milk ratio of 0.15. This finding implies
that the concentrations of breast milk exceeded
those of the maternal plasma, therefore, appearing
to be concentrated in breast milk.
Toxicities and teratogenesis have been studied
in animal models. 1,11 Chromosomal damage was ob-
served in cultured human lymphocytes at 200 Ixg/
ml, which is 25 times the peak levels achieved with
IV dosing in pregnancy but not -<125 Ixg/ml. An
ongoing registry established by the Burroughs Well-
come (now Glaxo Wellcome) Company continues to
accumulate the results of pregnancies prospectively
exposed to acyclovir. The most recent registry in-
terim report listed 847 prospectively exposed preg-
nancies (personal communication). The informa-
tion derived from this registry will be useful in
the evaluation of any clinically significant effects
of acyclovir in pregnancy.
Acyclovir has been used in primary genital her-
pes during pregnancy. Several studies have indi-
cated that primary genital herpes is associated with
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Fig. I. Lesions of eczema herpeticum. Note the extensive involvement and epithelial destruction
caused by HSV.
a higher incidence of obstetric and perinatal compli-
cations. The predominant mechanism of poor out-
come appears to be an increased incidence of pre-
mature labor and delivery, lz Case reports have also
described the use of acyclovir in primary genital
herpes in patients with premature rupture of the
membranes. 13
Life-threatening, disseminated HSV infection in
pregnancy has been treated with acyclovir.
4 This
form of HSV infection usually occurs in the immu-
nosuppressed or immunocompromised host, but
can occur in an immunocompetent adult. It seems
likely in the current setting of an HIV epidemic
that this problem may be faced in ever-increasing
numbers of pregnant individuals. Other potentially
life-threatening maternal diseases including acute
varicella pneumonia complicating pregnancy have
also been treated with IV acyclovir.5
Acyclovir is an effective antiviral agent in the
treatment of serious herpes infections. There ap-
pears to be a low morbidity related to its use during
pregnancy. The utilization of acyclovir for serious
disease with potentially life-threatening conse-
quences during pregnancy appears indicated. We
believe that the treatment of eczema herpeticum
is consistent with the CDC’s 1989 treatment guide-
lines which states that, "In the presence of life-
threatening maternal HSV infections, acyclovir ad-
ministered IV is probably of value.’’6
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